Statin Adjunctive Therapy for Tuberculosis Treatment

Por Alffenaar, Jan-Willem C., Akkerman, Onno W., van Hest, Rob
Publicado no Antimicrob Agents Chemother (2016)

High voriconazole trough levels in relation to hepatic function: how to adjust the dosage?

Por Alffenaar, Jan-Willem C, de Vos, Tessa, Uges, Donald R A, Daenen, Simon M G J
Publicado em 2009

Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams

Por Bolhuis, Mathieu S., Panday, Prashant N., Pranger, Arianna D., Kosterink, Jos G. W., Alffenaar, Jan-Willem C.
Publicado em 2011

Susceptibility Testing of Antibiotics That Degrade Faster than the Doubling Time of Slow-Growing Mycobacteria: Ertapenem Sterilizing Effect versus Mycobacterium tuberculosis

Por Srivastava, Shashikant, van Rijn, Sander P., Wessels, A. Mireille A., Alffenaar, Jan-Willem C., Gumbo, Tawanda
Publicado no Antimicrob Agents Chemother (2016)

Clarithromycin Significantly Increases Linezolid Serum Concentrations

Por Bolhuis, Mathieu S., van Altena, Richard, Uges, Donald R. A., van der Werf, Tjip S., Kosterink, Jos G. W., Alffenaar, Jan-Willem C.
Publicado em 2010

Adequate Design of Pharmacokinetic-Pharmacodynamic Studies Will Help Optimize Tuberculosis Treatment for the Future

Por Sturkenboom, Marieke G. G., Akkerman, Onno W., Bolhuis, Mathieu S., de Lange, Wiel C. M., van der Werf, Tjip S., Alffenaar, Jan-Willem C.
Publicado no Antimicrob Agents Chemother (2015)

Pharmacodynamics of Voriconazole in Children: Further Steps along the Path to True Individualized Therapy

Por Huurneman, Luc J., Neely, Michael, Veringa, Anette, Docobo Pérez, Fernando, Ramos-Martin, Virginia, Tissing, Wim J., Alffenaar, Jan-Willem C., Hope, William
Publicado no Antimicrob Agents Chemother (2016)

Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting

Por van’t Boveneind-Vrubleuskaya, Natasha, Daskapan, Alper, Kosterink, Jos G. W., van der Werf, Tjip S., van den Hof, Susan, Alffenaar, Jan-Willem C.
Publicado no PLoS One (2016)

Phenytoin-induced reduction of voriconazole serum concentration is not compensated by doubling the dosage

Por Alffenaar, Jan-Willem C, van der Elst, Kim C M, Uges, Donald R A, Kosterink, Jos G W, Daenen, Simon M G J
Publicado em 2009

Determination of Bedaquiline in Human Serum Using Liquid Chromatography-Tandem Mass Spectrometry

Por Alffenaar, Jan-Willem C., Bolhuis, Mathieu, van Hateren, Kai, Sturkenboom, Marieke, Akkerman, Onno, de Lange, Wiel, Greijdanus, Ben, van der Werf, Tjip, Touw, Daan
Publicado no Antimicrob Agents Chemother (2015)

The effect of inflammation on voriconazole trough concentrations in children

Por ter Avest, Mendy, Veringa, Anette, van den Heuvel, Edwin R., Kosterink, Jos G. W., Schölvinck, Elisabeth H., Tissing, Wim J. E., Alffenaar, Jan‐Willem C.
Publicado no Br J Clin Pharmacol (2016)

Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients

Por Hoppentocht, Marcel, Akkerman, Onno W., Hagedoorn, Paul, Alffenaar, Jan-Willem C., van der Werf, Tjip S., Kerstjens, Huib A. M., Frijlink, Henderik W., de Boer, Anne H.
Publicado no PLoS One (2016)

Therapeutic Drug Monitoring of Posaconazole: an Update

Por Dekkers, Bart G. J., Bakker, Martijn, van der Elst, Kim C. M., Sturkenboom, Marieke G. G., Veringa, Anette, Span, Lambert F. R., Alffenaar, Jan-Willem C.
Publicado no Curr Fungal Infect Rep (2016)

Clinical Validation of the Analysis of Fluconazole in Oral Fluid in Hospitalized Children

Por van der Elst, Kim C. M., van Alst, Manouche, Lub-de Hooge, Marjolijn N., van Hateren, Kai, Kosterink, Jos G. W., Alffenaar, Jan-Willem C., Schölvinck, Elisabeth H.
Publicado no Antimicrob Agents Chemother (2014)

Low but Sufficient Anidulafungin Exposure in Critically Ill Patients

Por van Wanrooy, Marjolijn J. P., Rodgers, Michael G. G., Uges, Donald R. A., Arends, Jan P., Zijlstra, Jan G., van der Werf, Tjip S., Kosterink, Jos G. W., Alffenaar, Jan-Willem C.
Publicado em 2014

Limited-Sampling Strategies for Anidulafungin in Critically Ill Patients

Por van Wanrooy, Marjolijn J. P., Proost, Johannes H., Rodgers, Michael G. G., Zijlstra, Jan G., Uges, Donald R. A., Kosterink, Jos G. W., van der Werf, Tjip S., Alffenaar, Jan-Willem C.
Publicado no Antimicrob Agents Chemother (2015)

Dried Blood Spot Analysis Suitable for Therapeutic Drug Monitoring of Voriconazole, Fluconazole, and Posaconazole

Por van der Elst, Kim C. M., Span, Lambert F. R., van Hateren, Kai, Vermeulen, Karin M., van der Werf, Tjip S., Greijdanus, Ben, Kosterink, Jos G. W., Uges, Donald R. A., Alffenaar, Jan-Willem C.
Publicado em 2013

Inflammation Is Associated with Voriconazole Trough Concentrations

Por van Wanrooy, Marjolijn J. P., Span, Lambert F. R., Rodgers, Michael G. G., van den Heuvel, Edwin R., Uges, Donald R. A., van der Werf, Tjip S., Kosterink, Jos G. W., Alffenaar, Jan-Willem C.
Publicado no Antimicrob Agents Chemother (2014)

Pharmacokinetic Modeling and Optimal Sampling Strategies for Therapeutic Drug Monitoring of Rifampin in Patients with Tuberculosis

Por Sturkenboom, Marieke G. G., Mulder, Leonie W., de Jager, Arthur, van Altena, Richard, Aarnoutse, Rob E., de Lange, Wiel C. M., Proost, Johannes H., Kosterink, Jos G. W., van der Werf, Tjip S., Alffenaar, Jan-Willem C.
Publicado no Antimicrob Agents Chemother (2015)

Low Caspofungin Exposure in Patients in Intensive Care Units

Por van der Elst, Kim C. M., Veringa, Anette, Zijlstra, Jan G., Beishuizen, Albertus, Klont, Rob, Brummelhuis-Visser, Petra, Uges, Donald R. A., Touw, Daan J., Kosterink, Jos G. W., van der Werf, Tjip S., Alffenaar, Jan-Willem C.
Publicado no Antimicrob Agents Chemother (2017)